Liberty Wealth Management’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17
Closed -$1K 797
2021
Q3
$1K Hold
17
﹤0.01% 1132
2021
Q2
$2K Hold
17
﹤0.01% 935
2021
Q1
$2K Hold
17
﹤0.01% 826
2020
Q4
$2K Hold
17
﹤0.01% 823
2020
Q3
$2K Hold
17
﹤0.01% 773
2020
Q2
$4K Buy
+17
New +$6.47K ﹤0.01% 655

Other funds holding NXTC

Liberty Wealth Management's NXTC Position: Q4 2021 in Review

Liberty Wealth Management sold out of NextCure (NXTC) in Q4 2021, closing a stake of 17 shares — an estimated $1K sold.

Liberty Wealth Management first reported a position in NXTC in Q2 2020 and held it in 6 quarters. The position peaked at $4K in Q2 2020. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

  • Liberty Wealth Management reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 17 NextCure shares in Q4 2021, an estimated $1K.
  • Liberty Wealth Management first reported a position in NextCure in Q2 2020 and held it in 6 quarters.
  • Liberty Wealth Management's NextCure position peaked at $4K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.